These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4573316)

  • 1. Interaction between levodopa and methyldopa.
    Gibberd FB; Small E
    Br Med J; 1973 Apr; 2(5858):90-1. PubMed ID: 4573316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
    Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Fehling C; Bell MA
    N Engl J Med; 1972 Jan; 286(1):8-14. PubMed ID: 4550085
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergism of levodopa by alpha methyldopa.
    Fermaglich J; O'Doherty DS
    Trans Am Neurol Assoc; 1971; 96():231-4. PubMed ID: 5159089
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease.
    Sweet RD; Lee JE; McDowell F
    Trans Am Neurol Assoc; 1971; 96():59-65. PubMed ID: 5159130
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.
    Calne DB; Petrie A; Rao S; Reid JL; Vakil SD
    Br J Pharmacol; 1972 Jan; 44(1):162-4. PubMed ID: 5015036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of levodopa effect by systemic decarboxylase inhibition.
    Mars H
    Arch Neurol; 1973 Feb; 28(2):91-5. PubMed ID: 4683155
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methyldopa and levodopa].
    Chang CP
    Zhonghua Yi Xue Za Zhi; 1974; 7():439-41. PubMed ID: 4211508
    [No Abstract]   [Full Text] [Related]  

  • 9. Levodopa and pressor amine sensitivity in parkinsonism.
    Reid JL; Calne DB; George CF; Vakil SD
    Clin Pharmacol Ther; 1972; 13(3):400-6. PubMed ID: 5026378
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
    Calne DB; Reid JL; Vakil SD; Rao S; Petrie A; Pallis CA; Gawler J; Thomas PK; Hilson A
    Br Med J; 1971 Sep; 3(5777):729-32. PubMed ID: 4938431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A therapeutic paradox? Combined treatment of Parkinson's disease with levodopa and methyldopa.
    Kofman OS
    Arch Neurol; 1973 Aug; 29(2):120-1. PubMed ID: 4717719
    [No Abstract]   [Full Text] [Related]  

  • 12. Methyldopa as an adjunct to levodopa treatment of Parkinson's disease.
    Sweet RD; Lee JE; McDowell FH
    Clin Pharmacol Ther; 1972; 13(1):23-7. PubMed ID: 5008190
    [No Abstract]   [Full Text] [Related]  

  • 13. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
    Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387
    [No Abstract]   [Full Text] [Related]  

  • 14. Methyldopa or methyldopahydrazine as levodopa synergists.
    Fermaglich J; Chase TN
    Lancet; 1973 Jun; 1(7814):1261-2. PubMed ID: 4122619
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmenting the action of levodopa.
    Rao SK; Vakil SD; Calne DB; Hilson A
    Postgrad Med J; 1972 Nov; 48(565):653-6. PubMed ID: 4568331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-dopa and methyldopa on growth of mammary cancers in rats.
    Quadri SK; Kledzik GS; Meites J
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):759-61. PubMed ID: 4692007
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa in the treatment of Parkinsonism.
    Cotzias GC
    JAMA; 1971 Dec; 218(13):1903-8. PubMed ID: 5171066
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug therapy of parkinsonism.
    Yahr MD; Duvoisin RC
    N Engl J Med; 1972 Jul; 287(1):20-4. PubMed ID: 4555145
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi.
    Duvoisin RC; Marsden CD
    Brain Res; 1974 May; 71(1):178-82. PubMed ID: 4821419
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of Levodopa for Parkinsonism. Levodopa (Dopar, Larodopa).
    JAMA; 1971 Mar; 215(12):1969-72. PubMed ID: 4396120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.